SCHEMBL6858381

SCHEMBL6858381

Cc1cccc(N(c2ccc(N(c3ccc(N(c4cccc(C)c4)c4cccc5ccccc45)cc3)c3ccc(N(c4cccc(C)c4)c4cccc5ccccc45)cc3)cc2)c2cccc3ccccc23)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 8/20 0.45
CYP2A6 P11509 2/20 0.41
CYP1A2 P05177 2/20 0.41
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
NR1I2 O75469 1/20 0.37
LMNA P02545 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTR2B P41595 1/20 0.37
CYP51A1 Q16850 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MAOA P21397 1/20 0.35
DHFR P00374 1/20 0.35
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ACHE P22303 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13720896 0.98 SIGMAR1 (0.44) SIGMAR1CYP2A6CYP1A2ALDH1A1MAPT
SCHEMBL13721232 0.98 SIGMAR1 (0.44) SIGMAR1CYP2A6CYP1A2ALDH1A1MAPT
SCHEMBL4580938 0.98 SIGMAR1 (0.44) SIGMAR1CYP2A6CYP1A2ALDH1A1MAPT
SCHEMBL13720871 0.98 SIGMAR1 (0.44) SIGMAR1CYP2A6CYP1A2ALDH1A1MAPT
SCHEMBL13721359 0.98 SIGMAR1 (0.44) SIGMAR1CYP2A6CYP1A2ALDH1A1MAPT
SCHEMBL13721067 0.98 SIGMAR1 (0.44) SIGMAR1CYP2A6CYP1A2ALDH1A1MAPT
SCHEMBL12249724 0.95 SIGMAR1 (0.46) SIGMAR1CYP2A6CYP1A2ALDH1A1MAPT
SCHEMBL10053537 0.95 SIGMAR1 (0.48) SIGMAR1CYP2A6CYP1A2ALDH1A1MAPT
SCHEMBL1813433 0.94 SIGMAR1 (0.41) SIGMAR1CYP2A6CYP1A2ALDH1A1MAPT
SCHEMBL4579204 0.94 SIGMAR1 (0.41) SIGMAR1CYP2A6CYP1A2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9257663-B2 Organic electroluminescent element and display device SONY CORPORATION (JP) 2016-02-09 US disclosed
US-9105858-B2 Organic electroluminescent device and display apparatus JOLED INC. (JP) 2015-08-11 US disclosed
US-9105858-B2 Organic electroluminescent device and display apparatus JOLED INC. (JP) 2015-08-11 US disclosed
US-20150171356-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND DISPLAY DEVICE MAGNOLIA BLUE CORPORATION (JP) 2015-06-18 US disclosed
US-20150171356-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND DISPLAY DEVICE MAGNOLIA BLUE CORPORATION (JP) 2015-06-18 US disclosed
US-20150060837-A1 ORGANIC ELECTROLUMINESCENCE DEVICE SONY CORPORATION (JP) 2015-03-05 US disclosed
US-20150060837-A1 ORGANIC ELECTROLUMINESCENCE DEVICE SONY CORPORATION (JP) 2015-03-05 US disclosed
US-8906517-B2 Organic electroluminescence device SONY CORPORATION (JP) 2014-12-09 US disclosed
US-8872423-B2 Organic electroluminescent device and display device SONY CORPORATION (JP) 2014-10-28 US disclosed
US-8872423-B2 Organic electroluminescent device and display device SONY CORPORATION (JP) 2014-10-28 US disclosed
US-8530062-B2 Organic electroluminescent element and display SONY CORPORATION (JP) 2013-09-10 US disclosed
US-8530062-B2 Organic electroluminescent element and display SONY CORPORATION (JP) 2013-09-10 US disclosed
US-20100252823-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY APPARATUS SONY CORPORATION (JP) 2010-10-07 US disclosed
US-20100252823-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY APPARATUS SONY CORPORATION (JP) 2010-10-07 US disclosed
US-20080233387-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY DEVICE SONY CORPORATION (JP) 2008-09-25 US disclosed
US-20080233387-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY DEVICE SONY CORPORATION (JP) 2008-09-25 US disclosed
US-20040049080-A1 Novel triphenylamines and use thereof SHIROTA, YASUHIKO (JP) 2004-03-11 US disclosed
EP-1300390-A1 NOVEL TRIPHENYLAMINES AND USE THEREOF BANDO CHEMICAL INDUSTRIES, LTD. (JP) 2003-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040049080-A1 Novel triphenylamines and use thereof NAT1, TPR, PNMT SIGMAR1 1260/4885CYP2A6 2949/4885CYP1A2 388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.